Sanofi Revises Down 3Q 2015 Sales Figure to EUR9.46 Billion From EUR9.59 Billion Previously
October 12 2016 - 3:06AM
Dow Jones News
By Inti Landauro
PARIS--French pharmaceutical giant Sanofi SA (SAN.FR) Wednesday
revised down its sales figure for the third quarter last year,
ahead of the release of earnings for the third quarter of this year
slated for Oct. 28
The company said its aggregate sales in the third quarter of
last year were 9.46 billion euros ($10.30 billion), down from
EUR9.59 billion reported previously. The company said it had
reclassified EUR136 million in product sales from other
manufacturers at its Vaxserve vaccines supply and services unit as
other revenues.
Sanofi said its third-quarter results would include a $100
million charge related to a legal settlement. The charge will be
reported in the line "other current operating income/expenses," the
company said.
Write to Inti Landauro at inti.landauro@wsj.com
(END) Dow Jones Newswires
October 12, 2016 02:51 ET (06:51 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sanofi (NASDAQ:SNY)
Historical Stock Chart
From Apr 2023 to Apr 2024
